Cellectar Biosciences Inc
(CLRB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Operating Expenses | 3,910 | 3,622 | 3,959 | 3,385 | 3,964 |
| Operating Income | -3,910 | -3,622 | -3,959 | -3,385 | -3,964 |
| Other Income | 0 | 10 | 1 | 5 | 60 |
| Pre-tax Income | -3,910 | -3,612 | -3,958 | -3,380 | -3,904 |
| Net Income Continuous | -3,910 | -3,612 | -3,958 | -3,380 | -3,904 |
| Net Income | $-3,910 | $-3,612 | $-3,958 | $-3,380 | $-3,904 |
| EPS Basic Total Ops | -45.05 | -78.08 | -126.13 | -60.06 | -126.13 |
| EPS Basic Continuous Ops | -44.60 | -78.64 | -126.57 | -61.21 | -124.89 |
| EPS Diluted Total Ops | -45.05 | -78.08 | -126.13 | -60.06 | -126.13 |
| EPS Diluted Continuous Ops | -44.60 | -78.64 | -126.57 | -61.21 | -124.89 |
| EBITDA(a) | $-3,874 | $-3,587 | $-3,925 | $-3,352 | $-3,930 |